Heron Therapeutics, Inc.
METHOD OF ADMINISTERING EMULSION FORMULATIONS OF AN NK-1 RECEPTOR ANTAGONIST
Last updated:
Abstract:
Disclosed herein are methods of administering pharmaceutical formulations of a neurokinin-1 (NK-1) receptor antagonist to a subject in need of treatment of emesis.
Status:
Application
Type:
Utility
Filling date:
29 Jan 2019
Issue date:
1 Aug 2019